Cargando…

Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma

Glioblastoma (GBM) is a lethal cancer of the central nervous system with a median survival rate of 15 months with treatment. Thus, there is a critical need to develop novel therapies for GBM. Immunotherapy is emerging as a promising therapeutic strategy. However, current therapies for GBM, in partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malo, Courtney S., Khadka, Roman H., Ayasoufi, Katayoun, Jin, Fang, AbouChehade, Jackson E., Hansen, Michael J., Iezzi, Raymond, Pavelko, Kevin D., Johnson, Aaron J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124655/ https://www.ncbi.nlm.nih.gov/pubmed/30211113 http://dx.doi.org/10.3389/fonc.2018.00320

Ejemplares similares

Microglia and Perivascular Macrophages Act as Antigen Presenting Cells to Promote CD8 T Cell Infiltration of the Brain
por: Goddery, Emma N., et al.
Publicado: (2021)

Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail
por: Tritz, Zachariah P, et al.
Publicado: (2021)

The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma
por: Malo, Courtney S., et al.
Publicado: (2016)

Inkjet-Printed Graphene Sensors for the Bedside Detection of Tear Film pH
por: Chehade, Jackson Abou, et al.
Publicado: (2021)

TREM2 mediates MHCII-associated CD4(+) T cell response against gliomas
por: Zheng, Jiaying, et al.
Publicado: (2023)

Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8(+) T cell responses
por: Malo, Courtney S., et al.
Publicado: (2018)

CD48 is a key molecule of immunomodulation affecting prognosis in glioma
por: Zou, Cunyi, et al.
Publicado: (2019)

Retinitis pigmentosa associated with a mutation in BEST1
por: Dalvin, Lauren A., et al.
Publicado: (2016)

Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance
por: Zhang, Xu, et al.
Publicado: (2022)

Dynamics of central and peripheral immunomodulation in a murine glioma model
por: Kennedy, Benjamin C, et al.
Publicado: (2009)

Role of Memory T Cells in Allograft Rejection and Tolerance
por: Benichou, Gilles, et al.
Publicado: (2017)

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
por: Plate, Karl H., et al.
Publicado: (2012)

AN OPTIMIZED MOUSE PARABIOSIS PROTOCOL FOR INVESTIGATION OF AGING AND REJUVENATIVE MECHANISMS
por: Rodriguez, Sonia, et al.
Publicado: (2022)

The role of angiogenic growth factors in the immune microenvironment of glioma
por: Ge, Zhengmao, et al.
Publicado: (2023)

Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
por: Hou, Xiaoying, et al.
Publicado: (2023)

Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma
por: Ali, Meser M., et al.
Publicado: (2010)

Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses
por: Renner, Danielle N., et al.
Publicado: (2015)

Soluble CD40 Ligand Stimulates the Pro-Angiogenic Function of Peripheral Blood Angiogenic Outgrowth Cells via Increased Release of Matrix Metalloproteinase-9
por: Bou Khzam, Lara, et al.
Publicado: (2013)

Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017)

Malignant Transformation in Glioma Steered by an Angiogenic Switch: Defining a Role for Bone Marrow-Derived Cells
por: Xu, Raymond, et al.
Publicado: (2016)

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
por: Kong, Ziren, et al.
Publicado: (2018)

The Concept and Practice of Immunomodulation in Ayurveda and the Role of Rasayanas as Immunomodulators
por: Tripathi, J.S., et al.
Publicado: (1999)

Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells
por: Mesti, Tanja, et al.
Publicado: (2014)

Molecular biomarker‐guided anti‐angiogenic targeted therapy for malignant glioma
por: Yan, Chengrui, et al.
Publicado: (2019)

Schistosome immunomodulators
por: Acharya, Sreemoyee, et al.
Publicado: (2021)

Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege
por: Lorrey, Selena J, et al.
Publicado: (2023)

Growth Associated Protein 43 (GAP-43) as a Novel Target for the Diagnosis, Treatment and Prevention of Epileptogenesis
por: Nemes, Ashley D., et al.
Publicado: (2017)

BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19
por: Moulson, Aaron J., et al.
Publicado: (2021)

Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure
por: Liao, Songyan, et al.
Publicado: (2019)

Clinical pharmacology of alemtuzumab, an anti‐CD52 immunomodulator, in multiple sclerosis
por: Li, Z., et al.
Publicado: (2018)

Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability
por: Suidan, Georgette L, et al.
Publicado: (2012)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

Prognosis and immunoinfiltration analysis of angiogene-related genes in grade 4 diffuse gliomas
por: Liu, Hui, et al.
Publicado: (2023)

A Versatile Simple Capture Assay for Assessing the Structural Integrity of MHC Multimer Reagents
por: Reed, Brendan K., et al.
Publicado: (2015)

CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases
por: Heim, Xavier, et al.
Publicado: (2020)

Contrasting Roles for CD4 vs. CD8 T-Cells in a Murine Model of Virally Induced “T1 Black Hole” Formation
por: Pirko, Istvan, et al.
Publicado: (2012)

Immunomodulators for Asthma
por: Dimov, Vesselin V, et al.
Publicado: (2010)

Natural Immunomodulators
por: Ortuño-Sahagún, D., et al.
Publicado: (2017)

Immunomodulation in COVID-19
por: Ingraham, Nicholas E, et al.
Publicado: (2020)

Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption
por: Willenbring, Robin C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qf9kqhg80tsfv5dcl6bq253jfa